SHREE GANESH REMEDIES
Back to Balance Sheet
|
SHREE GANESH REMEDIES Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2020 | Mar2019 | |
|---|---|---|---|---|
| Total Current Liabilities | ₹24 Cr | ₹26 Cr | ₹10 Cr | ₹6.79 Cr |
What is the latest Total Current Liabilities ratio of SHREE GANESH REMEDIES ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹24 Cr |
| Mar2024 | ₹26 Cr |
| Mar2020 | ₹10 Cr |
| Mar2019 | ₹6.79 Cr |
How is Total Current Liabilities of SHREE GANESH REMEDIES Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹24 Cr | -6.65 | |
| Mar2024 | ₹26 Cr | 149.96 | |
| Mar2020 | ₹10 Cr | 52.89 | |
| Mar2019 | ₹6.79 Cr | - | |
Compare Total Current Liabilities of peers of SHREE GANESH REMEDIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SHREE GANESH REMEDIES | ₹792.8 Cr | -4.1% | -8.6% | 14.8% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹467,630.0 Cr | -0.1% | 0.5% | 14% | Stock Analytics | |
| DIVIS LABORATORIES | ₹218,972.0 Cr | -0.9% | 21.1% | 25.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,358.0 Cr | -1.3% | 1.1% | 32.7% | Stock Analytics | |
| CIPLA | ₹118,916.0 Cr | 0.2% | 2.1% | -5.1% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹97,824.0 Cr | 0.2% | -7.7% | -7.5% | Stock Analytics | |
SHREE GANESH REMEDIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SHREE GANESH REMEDIES | -4.1% |
-8.6% |
14.8% |
| SENSEX | 0.5% |
2.6% |
-3.7% |
You may also like the below Video Courses